Recent data on the household impacts of providing antiretroviral therapy to HIV-infected adults paints a much fuller picture of the economic footprint of treatment than previously possible. With evidence from treatment programs in western Kenya and several countries within sub-Saharan Africa, we discuss a range of benefits to the households of patients receiving treatment. These benefits begin with the labor market outcomes of treated patients, who are able to significantly increase their work hours within six months after they initiate treatment. In the same time period there are significant improvements in the nutritional status and school attendance of children in patients ’ households, which in turn can improve the future well being of ...
Abstract: Using longitudinal survey data collected over a period of two years, this paper examines t...
<div><p>Background</p><p>Country decisions to scale-up “test and treat” approaches for HIV depend on...
BACKGROUND:Country decisions to scale-up "test and treat" approaches for HIV depend on consideration...
While the clinical impact of receiving antiretroviral therapy (ART) on individuals living with HIV i...
Using longitudinal survey data collected in collaboration with a treatment program, this paper is th...
The provision of life-saving antiretroviral (ARV) treatment has emerged as a key component of the gl...
The provision of life-saving antiretroviral (ARV) treatment has emerged as a key component of the gl...
The provision of antiretroviral medications is a central component of the response to HIV/AIDS and c...
Using longitudinal survey data collected over a period of two years, this paper examines the impact ...
Federal expenditures are under scrutiny in the United States, and the merits of continuing and expan...
Using longitudinal survey data collected in Kenya, this paper estimates the longer-term impacts of a...
Using longitudinal survey data collected over a period of two years, this paper examines the impact ...
Background The economic effects of poor immunologic recovery among HIV-infected patients receiving a...
Abstract: Using longitudinal survey data collected over a period of two years, this paper examines t...
<div><p>Background</p><p>Country decisions to scale-up “test and treat” approaches for HIV depend on...
BACKGROUND:Country decisions to scale-up "test and treat" approaches for HIV depend on consideration...
While the clinical impact of receiving antiretroviral therapy (ART) on individuals living with HIV i...
Using longitudinal survey data collected in collaboration with a treatment program, this paper is th...
The provision of life-saving antiretroviral (ARV) treatment has emerged as a key component of the gl...
The provision of life-saving antiretroviral (ARV) treatment has emerged as a key component of the gl...
The provision of antiretroviral medications is a central component of the response to HIV/AIDS and c...
Using longitudinal survey data collected over a period of two years, this paper examines the impact ...
Federal expenditures are under scrutiny in the United States, and the merits of continuing and expan...
Using longitudinal survey data collected in Kenya, this paper estimates the longer-term impacts of a...
Using longitudinal survey data collected over a period of two years, this paper examines the impact ...
Background The economic effects of poor immunologic recovery among HIV-infected patients receiving a...
Abstract: Using longitudinal survey data collected over a period of two years, this paper examines t...
<div><p>Background</p><p>Country decisions to scale-up “test and treat” approaches for HIV depend on...
BACKGROUND:Country decisions to scale-up "test and treat" approaches for HIV depend on consideration...